Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Evaluation of the 3p21.3 tumour-suppressor gene cluster

Abstract

Deletions of the 3p21.3 region are a frequent and early event in the formation of lung, breast, kidney and other cancers. Intense investigation of allelic losses and the discovery of overlapping homozygous deletions in lung and breast tumour-cell lines have defined a minimal critical 120 kb deletion region containing eight genes and likely to harbor one or more tumour-suppressor genes (TSGs). The candidate genes are HYAL2, FUS1, Ras-associated factor 1 (RASSF1), BLU/ZMYND10, NPR2L, 101F6, PL6 and CACNA2D2. Recent research indicates that several of these genes can suppress the growth of lung and other tumour cells. Furthermore, some genes (RASSF1A and BLU/ZMYND10) are very frequently inactivated by non-classical mechanisms such as promoter hypermethylation resulting in loss of expression. These data indicate that the 120 kb critical deletion region at 3p21.3 may represent a TSG cluster with preferential inactivation of particular genes depending on tumour type. The eight genes within this region and their potential role in cancer will be the focus of this review.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Abe M, Ohira M, Kaneda A, Yagi Y, Yamamoto S, Kitano Y et al. (2005). CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 65: 828–834.

    CAS  PubMed  Google Scholar 

  • Agathanggelou A, Bieche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S et al. (2003a). Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res 63: 5344–5351.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Agathanggelou A, Cooper WN, Latif F . (2005). Role of the ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497–3508.

    CAS  PubMed  Google Scholar 

  • Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L et al. (2003b). Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22: 1580–1588.

    CAS  PubMed  Google Scholar 

  • Ahmed-Choudhury J, Agathanggelou A, Fenton SL, Ricketts C, Clark GJ, Maher ER et al. (2005). Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res 65: 2690–2697.

    CAS  PubMed  Google Scholar 

  • Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M et al. (2005). The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129: 156–169.

    CAS  PubMed  Google Scholar 

  • Alden KJ, Garcia J . (2001). Differential effect of gabapentin on neuronal and muscle calcium currents. J Pharmacol Exp Ther 297: 727–735.

    CAS  PubMed  Google Scholar 

  • Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N et al. (2001). ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 21: 6470–6483.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Anantharaman V, Aravind L . (2000). Cache - a signaling domain common to animal Ca(2+)-channel subunits and a class of prokaryotic chemotaxis receptors. Trends Biochem Sci 25: 535–537.

    CAS  PubMed  Google Scholar 

  • Aoyama Y, Avruch J, Zhang XF . (2004). Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene 23: 3426–3433.

    CAS  PubMed  Google Scholar 

  • Armesilla AL, Williams JC, Buch MH, Pickard A, Emerson M, Cartwright EJ et al. (2004). Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem 279: 31318–31328.

    CAS  PubMed  Google Scholar 

  • Bais AJ, Gardner AE, McKenzie OL, Callen DF, Sutherland GR, Kremmidiotis G . (2004). Aberrant CBFA2T3B gene promoter methylation in breast tumors. Mol Cancer 3: 22.

    PubMed  PubMed Central  Google Scholar 

  • Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP et al. (2005). The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to bax conformational change and cell death. Mol Cell 18: 637–650.

    CAS  PubMed  Google Scholar 

  • Barclay J, Balaguero N, Mione M, Ackerman SL, Letts VA, Brodbeck J et al. (2001). Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci 21: 6095–6104.

    CAS  PubMed  Google Scholar 

  • Bertrand P, Courel MN, Maingonnat C, Jardin F, Tilly H, Bastard C . (2005). Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness. Int J Cancer 113: 207–212.

    CAS  PubMed  Google Scholar 

  • Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E . (2004). CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 279: 26991–27007.

    CAS  PubMed  Google Scholar 

  • Brena RM, Plass C, Costello JF . (2006). Mining methylation for early detection of common cancers. PLoS Med 3: e479.

    PubMed  PubMed Central  Google Scholar 

  • Brodbeck J, Davies A, Courtney JM, Meir A, Balaguero N, Canti C et al. (2002). The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function. J Biol Chem 277: 7684–7693.

    CAS  PubMed  Google Scholar 

  • Carboni GL, Gao BN, Nishizaki M, Xu K, Minna JD, Roth JA et al. (2003). CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 22: 615–626.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen JD, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J et al. (2003). The t(1;3) breakpoint-spanning involved in clear cell renal cell genes LSAMP and NORE1 are carcinomas. Cancer Cell 4: 405–413.

    CAS  PubMed  Google Scholar 

  • Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW et al. (2004a). RASSF1A is a target tumor suppressor from 3p21 in nasopharyngeal carcinoma. Int J Cancer 109 839–847.

    CAS  PubMed  Google Scholar 

  • Chow LS, Lo KW, Kwong J, Wong AYH, Huang DP . (2004b). Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma. Oncol Rep 12: 781–787.

    CAS  PubMed  Google Scholar 

  • Csoka AB, Frost GI, Stern R . (2001). The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20: 499–508.

    CAS  PubMed  Google Scholar 

  • Csoka AB, Scherer SW, Stern R . (1999). Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 60: 356–361.

    CAS  PubMed  Google Scholar 

  • Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD et al. (2004). RASSFIA interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64: 4112–4116.

    CAS  PubMed  Google Scholar 

  • Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, Latif F . (2005). Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 65: 7653–7659.

    CAS  PubMed  Google Scholar 

  • Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP . (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315–319.

    CAS  PubMed  Google Scholar 

  • Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, Miller AD et al. (2003). Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc Natl Acad Sci USA 100: 4580–4585.

    CAS  PubMed  Google Scholar 

  • De las Heras M, Barsky SH, Hasleton P, Wagner M, Larson E, Egan J et al. (2000). Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J 16: 330–332.

    CAS  PubMed  Google Scholar 

  • Eckfeld K, Hesson L, Vos MD, Bieche I, Latif F, Clark GJ . (2004). RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res 64: 8688–8693.

    CAS  PubMed  Google Scholar 

  • Endoh M, Tamura G, Honda T, Homma N, Terashima M, Nishizuka S et al. (2005). RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. Br J Cancer 93: 1395–1399.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Enegd B, King JA, Stylli S, Paradiso L, Kaye AH, Novak U . (2002). Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 50: 1311–1318.

    PubMed  Google Scholar 

  • Falvella FS, Manenti G, Spinola M, Pignatiello C, Conti B, Pastorino U et al. (2006). Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene 25: 3934–3938.

    CAS  PubMed  Google Scholar 

  • Fenton SL, Dallol A, Agathanggelou A, Hesson L, Ahmed-Choudhury J, Baksh S et al. (2004). Identification of the E1A-regulated transcription factor p120(E4F) as an interacting partner of the RASSF1A candidate tumor suppressor gene. Cancer Res 64: 102–107.

    CAS  PubMed  Google Scholar 

  • Fischer WH, Schubert D . (1996). Characterization of a novel platelet-derived growth factor-associated protein. J Neurochem 66: 2213–2216.

    CAS  PubMed  Google Scholar 

  • Fletcher CF, Tottene A, Lennon VA, Wilson SM, Dubel SJ, Paylor R et al. (2001). Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J 15: 1288–1290.

    CAS  PubMed  Google Scholar 

  • Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ . (2006). Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 38: 540–549.

    CAS  PubMed  Google Scholar 

  • Gao B, Sekido Y, Maximov A, Saad M, Forgacs E, Latif F et al. (2000). Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem 275: 12237–12242.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gopalan B, Ito I, Branch CD, Stephens C, Roth JA, Ramesh R . (2004). Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response. Technol Cancer Res Treat 3: 647–657.

    CAS  PubMed  Google Scholar 

  • Gurnett CA, De Waard M, Campbell KP . (1996). Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 16: 431–440.

    CAS  PubMed  Google Scholar 

  • Harjes E, Harjes S, Wohlgemuth S, Muller KH, Krieger E, Herrmann C et al. (2006). GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1. Structure 14: 881–888.

    CAS  PubMed  Google Scholar 

  • Hateboer G, Gennissen A, Ramos YF, Kerkhoven RM, Sonntag-Buck V, Stunnenberg HG et al. (1995). BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J 14: 3159–3169.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hesson L, Bieche I, Krex D, Criniere E, Hoang-Xuan K, Maher ER et al. (2004). Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 23: 2408–2419.

    CAS  PubMed  Google Scholar 

  • Hesson L, Dallol A, Minna JD, Maher ER, Latif F . (2003). NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 22: 947–954.

    CAS  PubMed  Google Scholar 

  • Hesson LB, Cooper WN, Latif F . (2007). The role of RASSF1A methylation in cancer. Dis Markers 23: 73–87.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hesson LB, Wilson R, Morton D, Adams C, Walker M, Maher ER et al. (2005). CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 24: 3987–3994.

    CAS  PubMed  Google Scholar 

  • Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD et al. (1995). Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 1908.

    CAS  PubMed  Google Scholar 

  • Irimia M, Fraga MF, Sanchez-Cespedes M, Esteller M . (2004). CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer. Oncogene 23: 8695–8699.

    CAS  PubMed  Google Scholar 

  • Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD et al. (2004). Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther 11: 733–739.

    CAS  PubMed  Google Scholar 

  • Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S et al. (2005). Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Cancer Lett 225: 131–139.

    CAS  PubMed  Google Scholar 

  • Ivanov SV, Ward JM, Tessarollo L, McAreavey D, Sachdev V, Fananapazir L et al. (2004). Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol 165: 1007–1018.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C et al. (2002). Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 62: 2715–2720.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF et al. (2002). Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253–265.

    CAS  PubMed  Google Scholar 

  • Kitagawa D, Kajiho H, Negishi T, Ura S, Watanabe T, Wada T et al. (2006). Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation. EMBO J 25: 3286–3297.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Klugbauer N, Lacinova L, Marais E, Hobom M, Hofmann F . (1999). Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci 19: 684–691.

    CAS  PubMed  Google Scholar 

  • Kochetkova M, McKenzie OL, Bais AJ, Martin JM, Secker GA, Seshadri R et al. (2002). CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res 62: 4599–4604.

    CAS  PubMed  Google Scholar 

  • Kok K, Naylor SL, Buys CH . (1997). Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71: 27–92.

    CAS  PubMed  Google Scholar 

  • Kondo M, Ji L, Kamibayashi C, Tomizawa Y, Randle D, Sekido Y et al. (2001). Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene 20: 6258–6262.

    CAS  PubMed  Google Scholar 

  • Ladendorff NE, Wu S, Lipsick JS . (2001). BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb. Oncogene 20: 125–132.

    CAS  PubMed  Google Scholar 

  • Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH et al. (2006). Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol (in press).

  • LeBoeuf RD, Ban EM, Green MM, Stone AS, Propst SM, Blalock JE et al. (1998). Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry. J Biol Chem 273: 361–368.

    CAS  PubMed  Google Scholar 

  • Lepperdinger G, Mullegger J, Kreil G . (2001). Hyal2 – less active, but more versatile? Matrix Biol 20: 509–514.

    CAS  PubMed  Google Scholar 

  • Lepperdinger G, Strobl B, Kreil G . (1998). HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 273: 22466–22470.

    CAS  PubMed  Google Scholar 

  • Lerman MI, Minna JD . (2000). The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 60: 6116–6133.

    CAS  PubMed  Google Scholar 

  • Li F, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L et al. (2004a). Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res 64: 6438–6443.

    CAS  PubMed  Google Scholar 

  • Li JF, Wang FL, Protopopov A, Malyukova A, Kashuba V, Minna JD et al. (2004b). Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 23: 5941–5949.

    CAS  PubMed  Google Scholar 

  • Li Y, Luo L, Thomas DY, Kang CY . (1994). Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology 204: 266–278.

    CAS  PubMed  Google Scholar 

  • Liu SL, Miller AD . (2007). Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein. Oncogene 26: 789–801.

    CAS  PubMed  Google Scholar 

  • Lusher ME, Lindsey JC, Latif F, Pearson ADJ, Ellison DW, Clifford SC . (2002). Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res 62: 5906–5911.

    CAS  PubMed  Google Scholar 

  • Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH et al. (2005). Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 114: 219–223.

    CAS  PubMed  Google Scholar 

  • Michalowski MB, de Fraipont F, Michelland S, Entz-Werle N, Grill J, Pasquier B et al. (2006). Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 166: 74–81.

    CAS  PubMed  Google Scholar 

  • Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD et al. (2003). Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma. Oncogene 22: 6794–6801.

    CAS  PubMed  Google Scholar 

  • Mullegger J, Lepperdinger G . (2002). Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis. Mech Dev 111: 25–35.

    CAS  PubMed  Google Scholar 

  • Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M et al. (2004). Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363: 1283–1285.

    PubMed  Google Scholar 

  • Novak U, Stylli SS, Kaye AH, Lepperdinger G . (1999). Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res 59: 6246–6250.

    CAS  PubMed  Google Scholar 

  • Oh HJ, Lee KK, Song SJ, Jin MS, Song MS, Lee JH et al. (2006). Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res 66: 2562–2569.

    CAS  PubMed  Google Scholar 

  • Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP et al. (2002). The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21: 1381–1390.

    CAS  PubMed  Google Scholar 

  • Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH et al. (2005). High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 4: 1116–1122.

    CAS  PubMed  Google Scholar 

  • Polesello C, Huelsmann S, Brown NH, Tapon N . (2006). The Drosophila RASSF homolog antagonizes the hippo pathway. Curr Biol 16: 2459–2465.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J . (2004). Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381: 453–462.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Qiu GH, Tan LKS, Loh KS, Lim CY, Srivastava G, Tsai ST et al. (2004). The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress- responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23: 4793–4806.

    CAS  PubMed  Google Scholar 

  • Rabizadeh S, Xavier RJ, Ishiguro K, Bernabeortiz J, Lopez-Ilasaca M, Khokhlatchev A et al. (2004). The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem 279: 29247–29254.

    CAS  PubMed  Google Scholar 

  • Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD . (2001). Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA 98: 4443–4448.

    CAS  PubMed  Google Scholar 

  • Riquelme E, Tang M, Baez S, Diaz A, Pruyas M, Wistuba II et al. (2007). Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett 250: 100–106.

    CAS  PubMed  Google Scholar 

  • Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M et al. (1996). Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12: 1289–1297.

    CAS  PubMed  Google Scholar 

  • Scheel H, Hofmann K . (2003). A novel interaction motif, SARAH, connects three classes of tumor suppressor. Curr Biol 13: R899–R900.

    CAS  PubMed  Google Scholar 

  • Schenk PW, Brok M, Boersma AW, Brandsma JA, Den Dulk H, Burger H et al. (2003). Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol Pharmacol 64: 259–268.

    CAS  PubMed  Google Scholar 

  • Sekido Y, Ahmadian M, Wistuba, II, Latif F, Bader S, Wei MH et al. (1998). Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 16: 3151–3157.

    CAS  PubMed  Google Scholar 

  • Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N et al. (2006). A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 3: e486.

    PubMed  PubMed Central  Google Scholar 

  • Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA . (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309–4318.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Shuster S, Frost GI, Csoka AB, Formby B, Stern R . (2002). Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 102: 192–197.

    CAS  PubMed  Google Scholar 

  • Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK et al. (2004). The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129–137.

    CAS  PubMed  Google Scholar 

  • Stern R . (2004). Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83: 317–325.

    CAS  PubMed  Google Scholar 

  • Sundaresan V, Chung G, Heppell-Parton A, Xiong J, Grundy C, Roberts I et al. (1998). Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 17: 1723–1729.

    CAS  PubMed  Google Scholar 

  • Tommasi S, Dammann R, Zhang ZQ, Wang Y, Liu LM, Tsark WM et al. (2005). Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92–98.

    CAS  PubMed  Google Scholar 

  • Toole BP . (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528–539.

    CAS  PubMed  Google Scholar 

  • Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP . (1999). Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res 59: 4535–4541.

    CAS  PubMed  Google Scholar 

  • Tsubaki M, Takeuchi F, Nakanishi N . (2005). Cytochrome b561 protein family: expanding roles and versatile transmembrane electron transfer abilities as predicted by a new classification system and protein sequence motif analyses. Biochim Biophys Acta 1753: 174–190.

    CAS  PubMed  Google Scholar 

  • Udabage L, Brownlee GR, Nilsson SK, Brown TJ . (2005). The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205–217.

    CAS  PubMed  Google Scholar 

  • Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J et al. (2006). The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res 66: 9682–9690.

    CAS  PubMed  Google Scholar 

  • Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN et al. (2004). Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 64: 2969–2976.

    CAS  PubMed  Google Scholar 

  • van der Weyden L, Tachibana KK, Gonzalez MA, Adams DJ, Ng BL, Petty R et al. (2005). The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol 25: 8356–8367.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Vavvas D, Li X, Avruch J, Zhang XF . (1998). Identification of Nore1 as a potential Ras effector. J Biol Chem 273: 5439–5442.

    CAS  PubMed  Google Scholar 

  • Velasco G, Grkovic S, Ansieau S . (2006). New insights into BS69 functions. J Biol Chem 281: 16546–16550.

    CAS  PubMed  Google Scholar 

  • Vigdorovich V, Strong RK, Miller AD . (2005). Expression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2. J Virol 79: 79–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB et al. (2006). The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 281: 4557–4563.

    CAS  PubMed  Google Scholar 

  • Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ . (2000). Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275: 35669–35672.

    CAS  PubMed  Google Scholar 

  • Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ . (2003a). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem 278: 28045–28051.

    CAS  PubMed  Google Scholar 

  • Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F et al. (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64: 4244–4250.

    CAS  PubMed  Google Scholar 

  • Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ . (2003b). The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem 278: 21938–21943.

    CAS  PubMed  Google Scholar 

  • Wan J, Zhang W, Wu L, Bai T, Zhang M, Lo KW et al. (2006). BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Mol Cell Biol 26: 448–456.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wei G, Schaffner AE, Baker KM, Mansky KC, Ostrowski MC . (2003). Ets-2 interacts with co-repressor BS69 to repress target gene expression. Anticancer Res 23: 2173–2178.

    CAS  PubMed  Google Scholar 

  • Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM et al. (1996). Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 56: 1487–1492.

    CAS  PubMed  Google Scholar 

  • Wistuba, II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L et al. (2000). High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60: 1949–1960.

    CAS  PubMed  Google Scholar 

  • Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT et al. (2006). Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 119: 2821–2826.

    CAS  PubMed  Google Scholar 

  • Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI et al. (2006). Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett 234: 184–192.

    PubMed  Google Scholar 

  • Zaahl MG, Merryweather-Clarke AT, Kotze MJ, van der Merwe S, Warnich L, Robson KJ . (2004). Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum Genet 115: 409–417.

    CAS  PubMed  Google Scholar 

  • Zhang L, Underhill CB, Chen L . (1995). Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428–433.

    CAS  PubMed  Google Scholar 

  • Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G . (2007). Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer 120: 32–38.

    CAS  PubMed  Google Scholar 

  • Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD . (2001). Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249–255.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

FL was funded, in part, by Breast Cancer Campaign, CRUK and SPARKS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Latif.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hesson, L., Cooper, W. & Latif, F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 26, 7283–7301 (2007). https://doi.org/10.1038/sj.onc.1210547

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210547

Keywords

This article is cited by

Search

Quick links